<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00535561</url>
  </required_header>
  <id_info>
    <org_study_id>22-5</org_study_id>
    <nct_id>NCT00535561</nct_id>
  </id_info>
  <brief_title>Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism</brief_title>
  <official_title>Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism: A Randomized, Double Blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duzce University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duzce University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether iron deficiency anemia can be an indication for the treatment of
      subclinical hypothyroidism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      51 Patients presented to our university outpatient internal medicine clinic who are found to
      have iron deficiency anemia coexisting with subclinical hypothyroidism have been included in
      this study. Patients were randomly assigned to oral iron or oral iron plus levothyroxin
      therapy. The physician and the patients did not know who received oral iron only or oral iron
      plus levothyroxine treatment. Hematologic parameters as well as serum iron, ferritin and iron
      binding capacity were being measured at the beginning and 3 months after treatment in both
      groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Significant improvement in Hgb and RBC</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Significant improvement in serum iron, ferritin, TIBC and possibly in serum TSH and free T4 levels.</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Iron Deficiency Anemia</condition>
  <condition>Subclinical Hypothyroidism</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral iron treatment only- for iron deficiency anemia and subclinical hypothyroidism coexisting patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral iron plus levothyroxine treatment- for iron deficiency anemia and subclinical hypothyroidism coexisting patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferrous sulfate tablets 325 mg, po, TID</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferrous sulfate plus levothyroxine</intervention_name>
    <description>Combination of ferrous sulfate tablet 325mg plus levothyroxine tablet 25 micrograms, po, TID</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis and laboratory confirmation of iron deficiency anemia and
             subclinical hypothyroidism

          -  Must be able to swallow tablets

        Exclusion Criteria:

          -  Multifactorial anemia or anemia due to other reasons

          -  Iron deficiency anemia requiring urgent intervention- cardiac ischemia, severe anemia,
             GI or GU losses due to malignancy and or acute/subacute big loses by respiratory, Gİ,
             GU, etc. system

          -  Prior thyroid disorder and/or treatment history

          -  Presence of any other co-morbid disease like renal insufficiency/ failure, coronary
             heart disease, hypertension, diabetes mellitus, any endocrine system disease other
             than subclinical hypothyroidism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>23 Years</minimum_age>
    <maximum_age>73 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hakan Cinemre, Assit. Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Duzce University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duzce University School of Medicine</name>
      <address>
        <city>Duzce</city>
        <zip>81620</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Kong WM, Sheikh MH, Lumb PJ, Naoumova RP, Freedman DB, Crook M, Doré CJ, Finer N. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med. 2002 Apr 1;112(5):348-54. Erratum in: Am J Med 2002 Oct 1;113(5):442. Naoumova P [corrected to Naoumova Rossitza P]. Am J Med 2002 Aug 15;113(3):264.</citation>
    <PMID>11904108</PMID>
  </reference>
  <reference>
    <citation>Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004 Jan 14;291(2):228-38. Review.</citation>
    <PMID>14722150</PMID>
  </reference>
  <reference>
    <citation>Horton L, Coburn RJ, England JM, Himsworth RL. The haematology of hypothyroidism. Q J Med. 1976 Jan;45(177):101-23.</citation>
    <PMID>1257398</PMID>
  </reference>
  <reference>
    <citation>Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001 Jul 26;345(4):260-5. Review.</citation>
    <PMID>11474665</PMID>
  </reference>
  <reference>
    <citation>Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab. 2005 Jan;90(1):581-5; discussion 586-7.</citation>
    <PMID>15643019</PMID>
  </reference>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2007</study_first_submitted>
  <study_first_submitted_qc>September 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2007</study_first_posted>
  <last_update_submitted>February 16, 2012</last_update_submitted>
  <last_update_submitted_qc>February 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2012</last_update_posted>
  <keyword>iron deficiency anemia</keyword>
  <keyword>anemia</keyword>
  <keyword>hypothyroidism</keyword>
  <keyword>subclinical hypothyroidism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Deficiency Diseases</mesh_term>
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

